Drug middlemen are duking it out to buy their customers. Most Americans pick up their prescription drugs at the local ...

The latest trading day saw McKesson (MCK) settling at $479.06, representing a -0.02% change from its previous close.

We recently compiled a list of 10 Best Stocks To Buy Right Now According To Billionaire Cliff Asness. In this article, we ...

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Deutsche Bank analyst George Hill maintained a Buy rating on McKesson (MCK – Research Report) today and set a price target of $579.00.

Robert W. Baird analyst Eric Coldwell downgraded the rating on McKesson (MCK – Research Report) to a Hold today, setting a price target ...

McKesson Corporation (NYSE: MCK) will release its second quarter fiscal 2025 financial results after market close on Wednesday, November 6, 2024. The company will host a live webcast of the earnings ...

The global healthcare electronic data interchange (EDI) market was valued at approximately USD 4.83 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 9.6% from 2024 ...

Cardinal Health on Friday agreed to acquire community cancer center operator Integrated Oncology Network for $1.12 billion in ...

Today, Benzinga's options scanner identified 12 options transactions for McKesson. This is an unusual occurrence. The ...

McKesson Corporation MCK is well-poised for growth in the coming quarters, courtesy of its strong Biologics business. The optimism led by a decent first-quarter fiscal 2025 performance and improving ...